CKT more important than del(17p) in CLL, group findsDecember 22, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Brentuximab combinations highly active in Hodgkin lymphomaDecember 19, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
‘Father of hematopoietic cytokines’ diesDecember 16, 2014AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Reducing chemo drug’s cardiac side effectsDecember 15, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Antibody shows activity in relapsed/refractory NHLDecember 11, 2014Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
FDA approves drug for HCMDecember 11, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Encapsulating doxorubicin can reduce heart damageDecember 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
CLL drug can fight AML too, study suggestsDecember 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
Disordered methylation compromises CLL treatmentDecember 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
PFS improvement will translate to OS, speaker saysDecember 9, 2014Lymphoma & Plasma Cell DisordersTransplantationHodgkin Lymphoma
Mouse model reveals insight into CLL relapseDecember 8, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Health Canada approves ibrutinib for CLLDecember 7, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
People often dismiss cancer symptoms, survey suggestsDecember 6, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues